Quick Answer
Sensus Healthcare, Inc. reported Research And Development Expense of $7.78 million for the year ending 2025.
- Sensus Healthcare, Inc. showed an increase of +84.5% in Research And Development Expense from 2024 to 2025.
- This data is from Sensus Healthcare, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $334.1 thousand | Q3 2015: $358.5 thousand | Q1 2016: $293.4 thousand | Q2 2016: $413.6 thousand | Q3 2016: $389.8 thousand | Q1 2017: $1.14 million | Q2 2017: $1.16 million | Q3 2017: $1.50 million | Q1 2018: $1.50 million | Q2 2018: $1.57 million | Q3 2018: $1.71 million | Q1 2019: $1.97 million | Q2 2019: $1.93 million | Q3 2019: $1.57 million | Q1 2020: $1.23 million | Q2 2020: $1.15 million | Q3 2020: $941.0 thousand | Q1 2021: $661.0 thousand | Q2 2021: $925.0 thousand | Q3 2021: $744.0 thousand | Q1 2022: $728.0 thousand | Q2 2022: $827.0 thousand | Q3 2022: $746.0 thousand | Q1 2023: $1.10 million | Q2 2023: $822.0 thousand | Q3 2023: $1.08 million | Q1 2024: $926.0 thousand | Q2 2024: $866.0 thousand | Q3 2024: $863.0 thousand | Q1 2025: $2.61 million | Q2 2025: $1.47 million | Q3 2025: $1.82 million.
- Over the full 11 years of available data (2015 to 2025), Sensus Healthcare, Inc.'s Research And Development Expense has grown by 430.3%.
- Historical annual values: Fiscal year 2025: $7.78 million | Fiscal year 2024: $4.22 million | Fiscal year 2023: $3.68 million | Fiscal year 2022: $3.46 million | Fiscal year 2021: $3.44 million | Fiscal year 2020: $4.16 million | Fiscal year 2019: $6.42 million | Fiscal year 2018: $6.26 million | Fiscal year 2017: $5.49 million | Fiscal year 2016: $1.82 million | Fiscal year 2015: $1.47 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: